FDA Clearance Tracker · P050044-S021
VITAGEL SURGICAL HEMOSTAT
Last checked: Nov 20, 2026Latest source record: Oct 11, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Oct 11, 2013
Approved
Time to decision
715 days
Received Oct 27, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P050044-S021
- Device name
- VITAGEL SURGICAL HEMOSTAT
- Applicant
- Stryker Corp.
- Applicant location
- Kalamazoo, MI
- Received
- Oct 27, 2011
- Decided
- Oct 11, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P050044
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A NEW VERSION OF VITAGEL WHERE THE BOVINE THROMBIN COMPONENT IS REPLACED WITH RECOMBINANT HUMAN THROMBIN. THE PRODUCT, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME VITAGEL RT AND IS INDICATED IN SURGICAL PROCEDURES (OTHER THAN NEUROSURGICAL AND OPHTHALMIC) AS AN ADJUNCT TO HEMOSTASIS WHEN CONTROL OF BLEEDING BY LIGATURE OR CONVENTIONAL PROCEDURES IS INEFFECTIVE OR IMPRACTICAL.
Source documents
Other decisions for Stryker Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- HipCheck510(k)
K230045 · Decided Sep 29, 2023 · 266 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
K191259 · Decided Jul 12, 2019 · 63 days after receipt
Device type: Arthroscope (HRX) · Orthopedic Surgery
- HipCheck510(k)
K182359 · Decided Dec 13, 2018 · 105 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.